GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40123C00077NATIONAL ACADEMY OF SCIENCES

Overview

Award facts

Net obligations
$949.02K
$949,024of $949.02K potential value
Outlays (paid to date)
$949.02K
$949.02K paid of $949.02K obligated$949,024
Period of performance
Jun 30, 2023 to Jan 31, 2025
Ended
Modifications
2
Latest action Jun 17, 2026
Contract type
Definitive contract
PIID 75F40123C00077

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

EVALUATING THE SAFETY AND EFFICACY OF DRUGS FOR RARE DISEASES OR CONDITIONS IN THE UNITED STATES AND THE EUROPEAN UNION

Dates and value

Award date
Signed on Jun 30, 2023
Current value
$949,024Base and exercised options
Potential value (if all options are exercised)
$949,024

Obligations by fiscal year of action

  • FY2026: -$13 (de-obligation)
  • FY2023: $949,037

Total across 2 fiscal years: $949,024

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 17, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationWASHINGTON, DC
UEIPKFJZHG2MLG9
CAGE code1D969
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Nonprofit organizationTax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Human drugs; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Washington, District Of Columbia County, District Of Columbia 20418-0006
Congressional district (place of performance)
DC-98As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Not available for competitionB
Reason not competed
Authorized by statute (FAR 6.302-5(A)(2)(I))OTH
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
1

Solicitation and notices

Solicitation ID
FDA SOL 1266969(as reported)
Solicitation date
Jun 22, 2023

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
Yes - service where PBA is used.Y

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 30, 2023Base obligation at award: $949,037
Latest action
Jun 17, 2026 — CloseoutModification P00002; obligation change -$13; administrative: no change in scope or value
Latest substantive action
Jan 25, 2024 — Supplemental agreement (within scope)Modification P00001
Actions by type
  • Base award1
  • Supplemental agreement (within scope)1
  • Closeout1
3 actions recorded, Jun 30, 2023 to Jun 17, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$13
Latest action: change in base and all options
-$13

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
3

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2023/2023-0600-000
  • 075-X-0600-000
Object classes
  • 25.2: Other services from non-Federal sources
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression